Physician profile
James D Hurt
NPI 1194727743
$2,280.30
in general payments reported to CMS, 2019-2025
12 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $93.29 · 2021: $94.76 · 2022: $192 · 2023: $1,492 · 2024: $144 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,029 · Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,028.57 |
| Food and Beverage | $745.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,468.38 | 2019-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Abbvie INC. | $188.91 | 2022-2024 | |
| Alimera Sciences, INC. | $178.48 | 2019-2022 | |
| Harrow Eye, LLC | $123.63 | 2024 | Vevye |
| Regeneron Healthcare Solutions, INC. | $107.46 | 2020-2022 | |
| Apellis Pharmaceuticals, INC. | $66.04 | 2025 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $37.19 | 2025 | Xdemvy |
| Ani Pharmaceuticals, INC. | $30.76 | 2023 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $23.98 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.58 | 2019 | |
| Aerie Pharmaceuticals, INC. | $18.96 | 2020 | |
| Oyster Point Pharma, INC. | $16.93 | 2025 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hurt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.